Compare CRON & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRON | OCSL |
|---|---|---|
| Founded | N/A | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 961.2M | 1.1B |
| IPO Year | N/A | 2008 |
| Metric | CRON | OCSL |
|---|---|---|
| Price | $2.68 | $12.80 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | ★ 4.1M | 837.9K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 12.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.09 | ★ 0.39 |
| Revenue | $132,357,000.00 | ★ $316,801,000.00 |
| Revenue This Year | $17.63 | N/A |
| Revenue Next Year | $30.76 | $0.38 |
| P/E Ratio | ★ $29.16 | $32.46 |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $1.60 | $12.44 |
| 52 Week High | $3.43 | $16.29 |
| Indicator | CRON | OCSL |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 35.88 |
| Support Level | $2.62 | $12.61 |
| Resistance Level | $3.31 | $12.99 |
| Average True Range (ATR) | 0.25 | 0.20 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 25.24 | 14.67 |
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.